Trial Profile
SafeTy and Efficacy of Direct Oral Anticoagulant Versus Aspirin for Reduction Of RisK of CErebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation (STROKE-VT)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2021
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Aspirin; Dabigatran etexilate; Edoxaban; Rivaroxaban
- Indications Stroke
- Focus Therapeutic Use
- Acronyms STROKE-VT
- 30 Aug 2021 Status changed from discontinued to completed.
- 21 May 2018 Status changed from recruiting to discontinued.
- 21 Mar 2017 Status changed from not yet recruiting to recruiting.